Maccura Biotechnology Co (SZSE:300463) ROCE % : 5.22% (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Maccura Biotechnology Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Maccura Biotechnology Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 5.22%.

Maccura Biotechnology Co ROCE % Historical Data

The historical data trend for Maccura Biotechnology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maccura Biotechnology Co ROCE % Chart

Maccura Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

22.21

25.12

25.33

13.36

4.81

Maccura Biotechnology Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															6.89	1.06	8.09	5.27	5.22

Maccura Biotechnology Co ROCE % Calculation

Maccura Biotechnology Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	338.902	/	( ( (8168.35 - 1083.357)	+	(8119.249 - 1120.605) )	/ 2 )
	=	338.902	/	( (7084.993	+	6998.644)	/ 2 )
	=	338.902	/	7041.8185
	=	4.81 %

Maccura Biotechnology Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	366.436	/	( ( (8303.137 - 1242.789)	+	(8205.887 - 1238.842) )	/ 2 )
	=	366.436	/	( ( 7060.348	+	6967.045 )	/ 2 )
	=	366.436	/	7013.6965
	=	5.22 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Maccura Biotechnology Co (SZSE:300463) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Maccura Biotechnology Co ROCE % Related Terms

Thank you for viewing the detailed overview of Maccura Biotechnology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Maccura Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Maccura Biotechnology Co Ltd (SZSE:300463) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 8, 2nd Anhe Road, Hi-tech Zone, Chengdu, CHN, 611731

Website

https://www.maccura.com/

Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Executives

Guo Lei	Director
Wang Deng Ming	Directors, executives
Wang Lin	Supervisors
Wu Ming Jian	Directors, executives
Shi Wei	Directors, executives
Yang Hui	Supervisors
Zhou Yue Guo	Executives
Wang Zhen	Executives
Yu Ping	Executives
Zou Yuan	Supervisors
Xu Sheng Guo	Directors, executives
Liu Qi Lin	Directors, executives
Chu Jian Jun	Executives
Tang Yong	Director
Xu Jin Song	Executives

Maccura Biotechnology Co Headlines

No Headlines